Dorien Pastoors
@d_pastoors
Followers
163
Following
356
Media
34
Statuses
165
PhD student at Erasmus MC | Molecular biology | Enhancer regulation in leukemia | Swimming | Cooking | @[email protected] @ https://t.co/Aei7gbiZTo
Rotterdam
Joined March 2019
science.org
Incurable leukemias driven by the EVI1 oncoprotein can be reversed experimentally by blocking the binding to its cofactor CTBP2.
Very excited to share our preprint (& my first (co)first-author preprint🤩) about targeting EVI1 in AML by disrupting its interaction with co-factors CTBP1/2. https://t.co/4q5RlRQaNU
10
6
26
Second preprint now on biorxiv!! 🧵⬇️ thanks to all our co authors @MarijeHavermans @RogerMulet @SmeenkLeonie and others i cant find on here ! Also on bluesky 🦋: https://t.co/5zBEGIGlgj
@erasmusmcblood
Excited to share our preprint (@D_Pastoors): "MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia"! https://t.co/XX6RqEC1fa MECOM is a TF whose overexpression leads to aggressive AML and with an immature phenotype. [1/15]
0
1
1
It appears there is a new kid on the block that's doing really well. Over the last two months I lost about 5000 followers on Twitter/X but gained almost the same amount of followers on Bluesky. A fascinating migration. Follow me over there too: https://t.co/WxGHJdlAuo
22
27
142
New paper out in @JAMAOnc! 🚨 Real-world data (RWD) external control arms are gaining traction in prospective studies, but we need to balance their advantages with meeting evidentiary standards Our review highlights significant differences between RWD and trial data🧵(1/7)
2
5
3
The Erasmus Hematology Virtual Lecture Series starts again September 2, with a fantastic line up: @pimkin,@AlexBickMDPhD, @theclotthickens, @jonasschluter, @job_dekker, @NBahlis, @Elsa2Bernard Retweet and share with your colleagues and friends https://t.co/ICOMFc5jv5
2
36
70
Had a great time at #EHA2024! Lots of interesting talks and happy to share our work on DNMT3A mutations and DNA methylation damage in AML! @erasmusmcblood
0
2
18
Why taking a train earlier for the #oncode24am meeting in den bosch is definitely worth it ... 👀 Looking forward to another day of exciting science!
0
1
12
Thank you @marlies_vdbempt 🤩
Last day of #EHA2024, time flies when you are having fun! ⏱️ This morning’s session starts with a very elegant story presented by @DelwelRuud on targeting EVI1 complexes. Congrats @d_pastoors with the impressive work! 👏
0
0
8
Great molecular aspects of hematology organised by @erasmusmcblood @DelwelRuud with @ElsyDutchy & other fantastic (keynote) speakers in rainy Rotterdam ☔ I got to present, as well as other PhDs from our dept who did an amazing job @MassaarSanne @IsabelBr12 and Jenny Huang
2
4
18
Yayy! Looking forward to working together 🙌🤩
Last week I started my PhD on oncogenic super enhancer hijacking in AML at the Delwel Group @ErasmusMC! Excited to start this new chapter in such a stimulating and welcoming place. Check out these stunning Rotterdam views from the Haematology department -
1
0
6
Developing a predictive model to stratify meeting cookies at the molecular aspects meeting into +chocolate and -chocolate with @LetiziaM24 . So far we have 100% precision!!! (Other people helped with eating )
0
0
4
GATA2AS is a novel GATA2 and HBG activator through distinct mechanisms. https://t.co/0Mro4T60sZ
#redcellsironanderythropoiesis
0
5
18
Interview from @ErasmusMC about our Science Advances article about the use of AlphaFold to find ways to target protein-protein interactions (in Dutch) @erasmusmcblood @DelwelRuud
amazingerasmusmc.nl
Van flubberig ongrijpbaar eiwit tot mogelijk aangrijpingspunt voor een medicijn tegen een agressieve vorm van acute leukemie. De onderzoekgroep van prof. Ruud Delwel van het Erasmus MC ontdekte met...
0
1
7
YESSS very excited 🤩🤩 very much looking forward to it
Welcome @MicrobiomDigest! We are very excited to host you at @erasmusmcblood!
0
0
1
Proud of the work by Dorien Pastoors and the rest of my fantastic team and collaborators. Read it in "Science Advances"! Oncogene EVI1 drives acute myeloid leukemia via a targetable interaction with CTBP2
pubmed.ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) driven by the activation of EVI1 due to chromosome 3q26/MECOM rearrangements is incurable. Because transcription factors such as EVI1 are notoriously hard to target,...
1
6
36
Wooo check out my friend @vries_fjord taking over Dutch science Twitter with her import and literally (hopefully) cool & very important research!! 🌏🦸🏼♀️
Goedemorgen☕️! Deze week zal ik @vries_fjord dit account gaan beheren. Voor mijn PhD onderzoek ik fjorden en gletsjers in Groenland🇬🇱.
0
0
3
MBD4U BY @MassaarSanne with beautiful models showing why you want MBD4 in your life and what happens if you don't. Very well done and I'm sure many great ones will follow!! 👏🏼👏🏼👏🏼 @erasmusmcblood at the @danieldenhoed annual retreat
0
1
3
Congratulations @maadulon & coauthors on a very cool and interesting publication now out in print! ⬇️⬇️ Impressive work on beautiful 🥺, but challenging cell type that made it into stunning figures 😍
1
0
5
Congratulations to @RogerMulet for the thesis of the year Swammerdam award and lecture at the Dutch Hematology conference #DHC24 @DelwelRuud @erasmusmcblood 🤩
4
1
11